Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies

被引：0
|
作者：
Vinicius L. Ferreira
Felipe F. Mainka
Astrid Wiens
Roberto Pontarolo
机构：
[1] Universidade Federal do Paraná,Department of Pharmacy, Pharmaceutical Sciences Postgraduate Programme
来源：
Clinical Drug Investigation | 2023年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：669 / 680
页数：11
相关论文
共 50 条
  • [1] Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies
    Ferreira, Vinicius L.
    Mainka, Felipe F.
    Wiens, Astrid
    Pontarolo, Roberto
    CLINICAL DRUG INVESTIGATION, 2023, 43 (09) : 669 - 680
  • [2] The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis
    Hou, Min
    Xing, Haiyan
    Cai, Yongqing
    Li, Bin
    Wang, Xianfeng
    Li, Pan
    Hu, Xiaolin
    Chen, Jianhong
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [3] The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis
    Min Hou
    Haiyan Xing
    Yongqing Cai
    Bin Li
    Xianfeng Wang
    Pan Li
    Xiaolin Hu
    Jianhong Chen
    The Journal of Headache and Pain, 2017, 18
  • [4] Efficacy and safety of anti-calcitonin gene-related peptide monoclonal antibodies for treatment of chronic migraine: A systematic review and network meta-analysis
    Soni, Prashant
    Chawla, Evanka
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 209
  • [5] Calcitonin gene-related peptide (CGRP) monoclonal antibodies for migraine
    Giffin, Nicola J.
    PRACTICAL NEUROLOGY, 2023, 23 (03) : 200 - +
  • [6] Adherence and persistence associated with calcitonin gene-related peptide monoclonal antibodies compared to non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine
    Foster, S. A.
    Manjelievskaia, J.
    Ford, J. H.
    Ye, W.
    Perry, A.
    Schuh, K.
    Wenzel, R.
    HEADACHE, 2021, 61 : 54 - 54
  • [7] Switching associated with initiation of calcitonin gene-related peptide monoclonal antibodies versus non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine
    Foster, S. A.
    Manjelievskaia, J.
    Ford, J. H.
    Ye, W.
    Perry, A.
    Schuh, K.
    Wenzel, R.
    HEADACHE, 2021, 61 : 75 - 76
  • [8] Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studies
    Mitsikostas, Dimos D.
    Reuter, Uwe
    CURRENT OPINION IN NEUROLOGY, 2017, 30 (03) : 272 - 280
  • [9] Effectiveness of Calcitonin Gene-Related Peptide Receptor Antagonists for Migraine Treatment: A Meta-Analysis
    Pak, Kyoungjune
    Kim, Jiyoung
    Lee, Gha-Hyun
    Cho, Jae Wook
    Kim, Hyun-Woo
    EUROPEAN NEUROLOGY, 2022, 85 (03) : 195 - 201
  • [10] The efficacy and safety of calcitonin gene-related peptide monoclonal antibody for episodic migraine: a meta-analysis
    Yuhan Zhu
    Yanyan Liu
    Jing Zhao
    Qingqing Han
    Lei Liu
    Xiaoxu Shen
    Neurological Sciences, 2018, 39 : 2097 - 2106
12345